These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23960185)

  • 21. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The case for adjuvant chemoradiation for pancreatic cancer.
    Garofalo M; Flannery T; Regine W
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):403-16. PubMed ID: 16549335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recruitment of adolescents and young adults to cancer clinical trials--international comparisons, barriers, and implications.
    Fern LA; Whelan JS
    Semin Oncol; 2010 Apr; 37(2):e1-8. PubMed ID: 20494693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy of pancreatic cancer.
    Hilbig A; Oettle H
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with enrollment in cancer genetics research.
    Ford BM; Evans JS; Stoffel EM; Balmaña J; Regan MM; Syngal S
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1355-9. PubMed ID: 16835336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing the current challenges of non-small-cell lung cancer clinical trial accrual.
    Curran WJ; Schiller JH; Wolkin AC; Comis RL;
    Clin Lung Cancer; 2008 Jul; 9(4):222-6. PubMed ID: 18650170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
    Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
    Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
    [No Abstract]   [Full Text] [Related]  

  • 33. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?
    Pasetto LM; Jirillo A; Stefani M; Monfardini S
    Anticancer Res; 2003; 23(3C):2805-13. PubMed ID: 12926117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2011 Apr; 17(7):1947-55. PubMed ID: 21447723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.
    Porter M; Ramaswamy B; Beisler K; Neki P; Single N; Thomas J; Hofacker J; Caligiuri M; Carson WE
    Ann Surg Oncol; 2016 Jul; 23(7):2146-52. PubMed ID: 26790668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.
    Grunfeld E; Zitzelsberger L; Coristine M; Aspelund F
    Cancer; 2002 Oct; 95(7):1577-83. PubMed ID: 12237928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations.
    Ruther NR; Mathiason MA; Wee SK; Emmel AE; Go RS
    Am J Clin Oncol; 2015 Dec; 38(6):575-82. PubMed ID: 24517955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.
    Hirsch BR; Locke SC; Abernethy AP
    J Oncol Pract; 2016 Apr; 12(4):e350-8. PubMed ID: 27026649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Trials in Pancreatic Cancer: A Long Slog.
    Enzler T; Bates S
    Oncologist; 2017 Dec; 22(12):1424-1426. PubMed ID: 28982802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence.
    Tran G; Harker M; Chiswell K; Unger JM; Fleury ME; Hirsch B; Miller K; d'Almada P; Tibbs S; Zafar SY
    JCO Clin Cancer Inform; 2020 Jan; 4():35-49. PubMed ID: 31977253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.